Evaluation and management of bradydysrhythmias in the emergency department.

Emerg Med Pract

Assistant Professor, Section of Emergency Medicine, Baylor College of Medicine, Houston, TX.

Published: September 2013

Bradydysrhythmias represent a collection of cardiac conduction abnormalities that span the spectrum of emergency presentations, from relatively benign conditions to conditions that represent serious, life-threatening emergencies. This review presents the electrocardiographic findings seen in common bradydysrhythmias and emphasizes prompt recognition of these patterns. Underlying etiologies that may accompany these conduction abnormalities are discussed, including bradydysrhythmias that are reflex mediated (including trauma induced) and those with metabolic, environmental, infectious, and toxicologic causes. Evidence regarding the management of bradydysrhythmias in the emergency department is limited; however, there are data to guide the approach to the unstable bradycardic patient. When decreased end-organ perfusion is present, the use of atropine, beta agonists, and transcutaneous or transvenous pacing may be required.

Download full-text PDF

Source

Publication Analysis

Top Keywords

management bradydysrhythmias
8
bradydysrhythmias emergency
8
emergency department
8
conduction abnormalities
8
bradydysrhythmias
5
evaluation management
4
department bradydysrhythmias
4
bradydysrhythmias represent
4
represent collection
4
collection cardiac
4

Similar Publications

Advanced cardiac life support (ACLS) emphasises the use of advanced airway management and ventilation, circulatory support and the appropriate use of drugs in resuscitation, as well as the identification of reversible causes of cardiac arrest. Extracorporeal cardiopulmonary resuscitation and organ donation, as well as special circumstances including drowning, pulmonary embolism and pregnancy are addressed. Resuscitation does not end with ACLS but must continue in post-resuscitation care.

View Article and Find Full Text PDF

Anesthetic Considerations for Angelman Syndrome: Case Series and Review of the Literature.

Anesth Pain Med

October 2017

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Background: Angelman syndrome is a rare neurodevelopmental disorder characterized by intellectual disability, severe speech impairment, ataxia, seizures, happy demeanor, distinctive craniofacial features, high vagal tone, and gamma-amino butyric acid receptor abnormalities. The aim of this report is to review our experience of patients with Angelman syndrome undergoing anesthetic management.

Methods: We retrospectively reviewed perioperative course of patients with Angelman syndrome who underwent procedures under anesthesia from 2000 to 2016.

View Article and Find Full Text PDF

Massive diltiazem and metoprolol overdose rescued with extracorporeal life support.

Am J Emerg Med

October 2017

Department of Emergency Medicine, Division of Cardiothoracic Surgery, University of California Davis Medical Center, Sacramento, CA, United States.

The management of overdoses of cardioactive medications in the emergency department can be challenging. The reversal of severe toxicity from one or more types of cardioactive medication may fail maximal medical therapies and require extreme invasive measures such as transvenous cardiac pacing and extracorporeal life support. We present a case of massive diltiazem and metoprolol overdose refractory to maximal medical therapy, including intravenous calcium, glucagon, vasopressors, high dose insulin, and lipid emulsion.

View Article and Find Full Text PDF

Successful treatment of flecainide-induced cardiac arrest with extracorporeal membrane oxygenation in the ED.

Am J Emerg Med

October 2015

Department of Emergency Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI, USA; Spectrum Health Hospitals, Grand Rapids, MI, USA; Grand Rapids Medical Education Partners Emergency Medicine Residency, Grand Rapids, MI, USA.

Article Synopsis
  • - Flecainide is a medication used to manage fast heart rhythms, but toxicity from the drug can lead to serious cardiovascular and neurological issues, mainly due to its effects on sodium channels.
  • - Treatment for flecainide toxicity has limited specific guidelines, often relying on methods used for other sodium-channel blockers, including IV fluids, sodium bicarbonate, and innovative therapies like intravenous fat emulsion and VA-ECMO.
  • - A case study of a 24-year-old woman who ingested flecainide showed that despite aggressive treatment, she experienced severe complications, including cardiac arrest; however, she ultimately recovered well after using VA-ECMO and other therapies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!